1.1 Articolo in rivista

1.1 Articolo in rivista: [39385] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 13.561 a 13.580 di 39.385

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease

2018-01-01 Panes, J; Garcia-Olmo, D; Van Assche, G; Colombel, Jf; Reinisch, W; Baumgart, Dc; Dignass, A; Nachury, M; Ferrante, M; Kazemi-Shirazi, L; Grimaud, Jc; De La Portilla, F; Goldin, E; Richard, Mp; Diez, Mc; Annese, V; Tagarro, I; Leselbaum, A; Danese, S

Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis

2020-01-01 Gracey, Eric; Vereecke, Lars; Mcgovern, Dermot; Fröhling, Mareike; Schett, Georg; Danese, Silvio; De Vos, Martine; Van den Bosch, Filip; Elewaut, Dirk

Which MRI Score and Technique Should Be Used for Assessing Crohn's Disease Activity?

2020-01-01 D'Amico, Ferdinando; Chateau, Thomas; Laurent, Valérie; Danese, Silvio; Peyrin-Biroulet, Laurent

Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy

2020-01-01 Cecconi, Maurizio; Piovani, Daniele; Brunetta, Enrico; Aghemo, Alessio; Greco, Massimiliano; Ciccarelli, Michele; Angelini, Claudio; Voza, Antonio; Omodei, Paolo; Vespa, Edoardo; Pugliese, Nicola; Parigi, Tommaso Lorenzo; Folci, Marco; Danese, Silvio; Bonovas, Stefanos

Etiopathogenesis of inflammatory bowel diseases

2006-01-01 Danese, S; Fiocchi, C

Role of Helicobacter pylori CagA(+) infection in determining oxidative DNA damage in gastric mucosa

2002-01-01 Papa, A; Danese, S; Sgambato, A; Ardito, R; Zannoni, G; Rinelli, A; Vecchio, Fm; Gentiloni-Silveri, N; Cittadini, A; Gasbarrini, G; Gasbarrini, A

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)

2014-01-01 Sebastian, S.; Hernández, V.; Myrelid, P.; Kariv, R.; Tsianos, E.; Toruner, M.; Marti-Gallostra, M.; A, Spinelli; van der Meulen-de Jong, A. E.; Yuksel, E. S.; Gasche, C.; Ardizzone, S.; Danese, S.

In the Presence of Conceptual Heterogeneity, Results of Network Meta-analysis Comparing Therapies in Crohn's Disease Need to Be Interpreted With Caution

2015-01-01 Bonovas, S; Moja, L; Danese, S

Targeting lymphatics in inflammatory bowel disease

2015-01-01 D'Alessio, S; Tacconi, C; Danese, S

FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF alpha Agents

2013-01-01 Guidi, L; Felice, C; Procoli, A; Bonanno, G; Martinelli, E; Marzo, M; Mocci, G; Pugliese, D; Andrisani, G; Danese, S; De Vitis, I; Papa, A; Armuzzi, A; Rutella, S

Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice

2008-01-01 Paclik, D; Berndt, U; Guzy, C; Dankof, A; Danese, S; Holzloehner, P; Rosewicz, S; Wiedenmann, B; Wittig, Bm; Dignass, Au; Sturm, A

Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties

2020-01-01 Tavares de Sousa, Helena; Estevinho, Maria Manuela; Peyrin-Biroulet, Laurent; Danese, Silvio; Dias, Cláudia Camila; Carneiro, Fátima; Magro, Fernando

Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study

2001-01-01 Gasbarrini, A; Anti, M; Franceschi, F; Armuzzi, A; Cotichini, R; Ojetti, V; Candelli, M; Lippi, Me; Paolucci, M; Cicconi, V; Cammarota, G; Danese, S; Silveri, Ng; Catananti, C; Pola, P; Stroffolini, T; Gasbarrini, G

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)

2019-01-01 Danese, S; Vermeire, S; Hellstern, P; Panaccione, R; Rogler, G; Fraser, G; Kohn, A; Desreumaux, P; Leong, Rw; Comer, Gm; Cataldi, F; Banerjee, A; Maguire, Mk; Li, C; Rath, N; Beebe, J; Schreiber, S

Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease

2017-01-01 Bonovas, S; Fiorino, G; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S

Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation

2005-01-01 Danese, S; Semeraro, S; Marini, M; Roberto, I; Armuzzi, A; Papa, A; Gasbarrini, A

Step-up and top-down approaches to the treatment of Crohn’s disease: early may already be too late

2008-01-01 Peyrin-Biroulet, L.; Bigard, M. A.; Malesci, A.; Danese, S.

Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease

2017-01-01 Hindryckx, P; Novak, G; Bonovas, S; Peyrin-Biroulet, L; Danese, S

Biosimilars in IBD: from theory to practice

2017-01-01 Danese, S; Bonovas, S; Peyrin-Biroulet, L

Surgical rates in the era of biological therapy: up, down or unchanged?

2017-01-01 Olivera, P; Spinelli, A; Gower-Rousseau, C; Danese, S; Peyrin-Biroulet, L

Titolo	Data di pubblicazione	Autore(i)
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease	1-gen-2018	Panes, J; Garcia-Olmo, D; Van Assche, G; Colombel, Jf; Reinisch, W; Baumgart, Dc; Dignass, A; Nachury, M; Ferrante, M; Kazemi-Shirazi, L; Grimaud, Jc; De La Portilla, F; Goldin, E; Richard, Mp; Diez, Mc; Annese, V; Tagarro, I; Leselbaum, A; Danese, S
Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis	1-gen-2020	Gracey, Eric; Vereecke, Lars; Mcgovern, Dermot; Fröhling, Mareike; Schett, Georg; Danese, Silvio; De Vos, Martine; Van den Bosch, Filip; Elewaut, Dirk
Which MRI Score and Technique Should Be Used for Assessing Crohn's Disease Activity?	1-gen-2020	D'Amico, Ferdinando; Chateau, Thomas; Laurent, Valérie; Danese, Silvio; Peyrin-Biroulet, Laurent
Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy	1-gen-2020	Cecconi, Maurizio; Piovani, Daniele; Brunetta, Enrico; Aghemo, Alessio; Greco, Massimiliano; Ciccarelli, Michele; Angelini, Claudio; Voza, Antonio; Omodei, Paolo; Vespa, Edoardo; Pugliese, Nicola; Parigi, Tommaso Lorenzo; Folci, Marco; Danese, Silvio; Bonovas, Stefanos
Etiopathogenesis of inflammatory bowel diseases	1-gen-2006	Danese, S; Fiocchi, C
Role of Helicobacter pylori CagA(+) infection in determining oxidative DNA damage in gastric mucosa	1-gen-2002	Papa, A; Danese, S; Sgambato, A; Ardito, R; Zannoni, G; Rinelli, A; Vecchio, Fm; Gentiloni-Silveri, N; Cittadini, A; Gasbarrini, G; Gasbarrini, A
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I)	1-gen-2014	Sebastian, S.; Hernández, V.; Myrelid, P.; Kariv, R.; Tsianos, E.; Toruner, M.; Marti-Gallostra, M.; A, Spinelli; van der Meulen-de Jong, A. E.; Yuksel, E. S.; Gasche, C.; Ardizzone, S.; Danese, S.
In the Presence of Conceptual Heterogeneity, Results of Network Meta-analysis Comparing Therapies in Crohn's Disease Need to Be Interpreted With Caution	1-gen-2015	Bonovas, S; Moja, L; Danese, S
Targeting lymphatics in inflammatory bowel disease	1-gen-2015	D'Alessio, S; Tacconi, C; Danese, S
FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNF alpha Agents	1-gen-2013	Guidi, L; Felice, C; Procoli, A; Bonanno, G; Martinelli, E; Marzo, M; Mocci, G; Pugliese, D; Andrisani, G; Danese, S; De Vitis, I; Papa, A; Armuzzi, A; Rutella, S
Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice	1-gen-2008	Paclik, D; Berndt, U; Guzy, C; Dankof, A; Danese, S; Holzloehner, P; Rosewicz, S; Wiedenmann, B; Wittig, Bm; Dignass, Au; Sturm, A
Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties	1-gen-2020	Tavares de Sousa, Helena; Estevinho, Maria Manuela; Peyrin-Biroulet, Laurent; Danese, Silvio; Dias, Cláudia Camila; Carneiro, Fátima; Magro, Fernando
Prevalence of and risk factors for Helicobacter pylori infection among healthcare workers at a teaching hospital in Rome: the Catholic University Epidemiological Study	1-gen-2001	Gasbarrini, A; Anti, M; Franceschi, F; Armuzzi, A; Cotichini, R; Ojetti, V; Candelli, M; Lippi, Me; Paolucci, M; Cicconi, V; Cammarota, G; Danese, S; Silveri, Ng; Catananti, C; Pola, P; Stroffolini, T; Gasbarrini, G
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)	1-gen-2019	Danese, S; Vermeire, S; Hellstern, P; Panaccione, R; Rogler, G; Fraser, G; Kohn, A; Desreumaux, P; Leong, Rw; Comer, Gm; Cataldi, F; Banerjee, A; Maguire, Mk; Li, C; Rath, N; Beebe, J; Schreiber, S
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease	1-gen-2017	Bonovas, S; Fiorino, G; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Adhesion molecules in inflammatory bowel disease: Therapeutic implications for gut inflammation	1-gen-2005	Danese, S; Semeraro, S; Marini, M; Roberto, I; Armuzzi, A; Papa, A; Gasbarrini, A
Step-up and top-down approaches to the treatment of Crohn’s disease: early may already be too late	1-gen-2008	Peyrin-Biroulet, L.; Bigard, M. A.; Malesci, A.; Danese, S.
Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease	1-gen-2017	Hindryckx, P; Novak, G; Bonovas, S; Peyrin-Biroulet, L; Danese, S
Biosimilars in IBD: from theory to practice	1-gen-2017	Danese, S; Bonovas, S; Peyrin-Biroulet, L
Surgical rates in the era of biological therapy: up, down or unchanged?	1-gen-2017	Olivera, P; Spinelli, A; Gower-Rousseau, C; Danese, S; Peyrin-Biroulet, L

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 13.561 a 13.580 di 39.385

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext33605
open3381
reserved2292
partially open99
embargoed7
mixed1